ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

Rocky Mountain REACH (RMT-REACH)

Active
Institution
University of Montana, MT
Principal investigator
Erica L Woodahl
Funding
$948K
Duration
2023–2027
Open portfolio
34/100

Moonbase score

Translational potential

See the breakdown ↓

Abstract

The Rocky Mountain Research Evaluation and Commercialization Hub (RMT-REACH) at the University of Montana (UM) will catalyze the emerging biomedical industry corridor in Montana and the surrounding states by establishing a hub to accelerate translation of academic discoveries into products that impact human health. Untapped opportunities exist in IDeA states to turn biomedical research discoveries into technologies that address pressing health needs and reduce disease burden for populations across the United States (US). We have partnered with 10 academic institutions across the IDeA states in the Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI) region—including a community, a technological, and a tribal college—as well as the Washington Entrepreneurial-REACH (WE-REACH) at the University of Washington to gain invaluable guidance from their leadership team. Academic discovery is indispensable for ensuring a pipeline of research for novel diagnostics, devices, and therapies, yet sustainable infrastructure to support academic innovators in resource-limited regions has yet to be fully realized. Geographically remote regions have unique challenges in developing and promoting commercialization and entrepreneurship, including lack of infrastructure, fewer opportunities to engage with innovators and subject matters experts, and lower levels of funding. Gaps in resource allocation contribute to higher rates of mortality and disease burden, and health systems in these areas are often late to implement health innovation when compared to their metropolitan counterparts. In order for health innovation to reach clinical usefulness for all people, we must consider geographic, infrastructural, and economic barriers at every stage of the biomedical research life cycle. We will accomplish our ultimate goals through the following aims: 1) Identify emerging biomedical discoveries with commercial viability in academic institutions within the four regional IDeA states supported by RMT-REACH, emphasizing discoveries that address disease burden in regions with less healthcare infrastructure; 2) Develop an innovative implementation system to enable support with gap funding, key subject matter experts in areas of product development, regulatory, reimbursement, legal, business development, and overall commercial strategy for academic researchers in resource-limited areas; 3) Provide funding and project management support for promising technologies and development teams to accelerate product definition studies; and 4) Elevate a WWAMI region-wide pro-entrepreneurial culture among academic investigators by engaging and mentoring biomedical innovators in rural and tribal institutions. With a strong leadership team providing complementary expertise and proven experience in entrepreneurial startups, RMT-REACH will train the next generation of biomedical innovators in entrepreneurship and product development, positively impact the regional economy, and bring products that address pressing health needs.

Research team

  • Erica L WoodahlPI
  • Karen Ethel BrownPI

LOADING MOONBASE SCORE

NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESU01Special Emphasis Panel[ZRG1-MCST-K(50)R]

Questions for University of Montana

Answered by the team behind this research.

Same researchers, same institution, scored first.